The Future of Digital Biomarker in Rheumatology
In this episode, we are joined by Patty de Groot, a leading expert in rheumatology and digital health innovation, to discuss her groundbreaking work on digital biomarkers and the integration of technology into rheumatology care.
We delve into the potential of digital biomarkers to enhance early diagnosis, personalize treatment, and streamline care delivery for patients with rheumatic diseases. Patty shares insights from her research, including the findings from her recent BMJ paper, the IPROLEPSIS project, and the use of design-thinking approaches to optimize healthcare workflows for rheumatologists.
The conversation explores critical topics, including the perspectives of healthcare professionals on adopting digital tools and the challenges of implementation.
Join us for this insightful discussion about the evolving landscape of rheumatology care, where digital innovation is poised to transform the way we diagnose, treat, and manage chronic conditions.
In November 2021 I started my research at the department of Rheumatology in the Erasmus MC. The focus of my project is on establishing the pains and gains of the current methods by which we monitor and mangage disease activity in Psoriatic Arthritis and Rheumatoid Arthritis. I have a special interest in how we can use the expertise of patients, medical specialists and other stakeholders to improve implementation of technology in current healthcare pathways.
Patty de Groot: The Future of Digital Biomarker in Rheumatology
If you like to get more intersting content please become a member or if you are already a member go to the member area directly: